The Garden State, called the “medicine chest” to the world, continues to show robust activity with life sciences firms accounting for nearly 30% of all Q2 leasing activity.
President Trump told CNBC his administration would initially levy a “small” pharma-specific tariff, followed by an increase to 150% in a year or so and then as high as 250%.
While the facility has had several run-ins in recent years with U.S. regulators, selling the site is part of Lilly’s broader global manufacturing strategy.
The Bloomington, Indiana facility is a fill-finish site for Regeneron’s Eylea HD and odronextamab and handles the final stages of drug preparation and packaging.
The South Korean manufacturer and exporter of biosimilars said it has been designated as the preferred bidder on a large-scale cGMP drug substance facility.
While the drugmaker provided few details on the plan, a new restructuring program is meant to align its global manufacturing to reflect changes in the business.
Although some analysts do not expect it to have a significant financial impact, others project tariffs could increase industry costs by $13 billion to $19 billion per year.
The agency’s new two-phase regulatory framework seeks to strengthen domestic supply chain and reduce foreign dependence on active pharmaceutical ingredients.
The Chinese CRDMO’s newest GMP-compliant facility in Wuxi adds seven million vials of annual capacity, expanding its bioconjugate drug product network.
Discover how automated calibration improves compliance, reduces human error, and increases efficiency in pharmaceutical manufacturing. This Beamex white paper explores the benefits...
Unlock the full potential of your GMP assets. Discover how life sciences organizations can optimize reliability, compliance, and performance with a data-driven approach to Asset...
Three of Cognite's chemical, refining, and energy customers take center stage in this product tour video that showcases why and how they are transforming their operations.
Are you making quick-enough progress on your industrial Gen AI journey? Learn what it actually takes to trust, deliver, and scale across operational use cases.
